My research focuses on morphology of gastrointestinal and hepatic diseases. I provide expertise in interpretation of histopathologic changes in a variety of animal models of gastrointestinal diseases to basic scientists at Vanderbilt. I also serve as Director for several research biorepositories and shared resources, including the Vanderbilt Digestive Diseases Research Center and the Western Division of the Cooperative Human Tissue Network.


The following timeline graph is generated from all co-authored publications.

Featured publications are shown below:

  1. Pharmacological blockade of ASCT2-dependent glutamine transport leads to antitumor efficacy in preclinical models. Schulte ML, Fu A, Zhao P, Li J, Geng L, Smith ST, Kondo J, Coffey RJ, Johnson MO, Rathmell JC, Sharick JT, Skala MC, Smith JA, Berlin J, Washington MK, Nickels ML, Manning HC (2018) Nat Med 24(2): 194-202
    › Primary publication · 29334372 (PubMed) · PMC5803339 (PubMed Central)
  2. p120-Catenin is an obligate haploinsufficient tumor suppressor in intestinal neoplasia. Short SP, Kondo J, Smalley-Freed WG, Takeda H, Dohn MR, Powell AE, Carnahan RH, Washington MK, Tripathi M, Payne DM, Jenkins NA, Copeland NG, Coffey RJ, Reynolds AB (2017) J Clin Invest 127(12): 4462-4476
    › Primary publication · 29130932 (PubMed) · PMC5707165 (PubMed Central)
  3. Cancer-associated fibroblasts promote directional cancer cell migration by aligning fibronectin. Erdogan B, Ao M, White LM, Means AL, Brewer BM, Yang L, Washington MK, Shi C, Franco OE, Weaver AM, Hayward SW, Li D, Webb DJ (2017) J Cell Biol 216(11): 3799-3816
    › Primary publication · 29021221 (PubMed) · PMC5674895 (PubMed Central)
  4. Dietary Manganese Promotes Staphylococcal Infection of the Heart. Juttukonda LJ, Berends ETM, Zackular JP, Moore JL, Stier MT, Zhang Y, Schmitz JE, Beavers WN, Wijers CD, Gilston BA, Kehl-Fie TE, Atkinson J, Washington MK, Peebles RS, Chazin WJ, Torres VJ, Caprioli RM, Skaar EP (2017) Cell Host Microbe 22(4): 531-542.e8
    › Primary publication · 28943329 (PubMed) · PMC5638708 (PubMed Central)
  5. Human alpha defensin 5 is a candidate biomarker to delineate inflammatory bowel disease. Williams AD, Korolkova OY, Sakwe AM, Geiger TM, James SD, Muldoon RL, Herline AJ, Goodwin JS, Izban MG, Washington MK, Smoot DT, Ballard BR, Gazouli M, M'Koma AE (2017) PLoS One 12(8): e0179710
    › Primary publication · 28817680 (PubMed) · PMC5560519 (PubMed Central)
  6. MTG16 is a tumor suppressor in colitis-associated carcinoma. McDonough EM, Barrett CW, Parang B, Mittal MK, Smith JJ, Bradley AM, Choksi YA, Coburn LA, Short SP, Thompson JJ, Zhang B, Poindexter SV, Fischer MA, Chen X, Li J, Revetta FL, Naik R, Washington MK, Rosen MJ, Hiebert SW, Wilson KT, Williams CS (2017) JCI Insight 2(16)
    › Primary publication · 28814670 (PubMed) · PMC5621889 (PubMed Central)
  7. Loss of claudin-3 expression induces IL6/gp130/Stat3 signaling to promote colon cancer malignancy by hyperactivating Wnt/β-catenin signaling. Ahmad R, Kumar B, Chen Z, Chen X, Müller D, Lele SM, Washington MK, Batra SK, Dhawan P, Singh AB (2017) Oncogene 36(47): 6592-6604
    › Primary publication · 28783170 (PubMed) · PMC6512312 (PubMed Central)
  8. BVES regulates c-Myc stability via PP2A and suppresses colitis-induced tumourigenesis. Parang B, Kaz AM, Barrett CW, Short SP, Ning W, Keating CE, Mittal MK, Naik RD, Washington MK, Revetta FL, Smith JJ, Chen X, Wilson KT, Brand T, Bader DM, Tansey WP, Chen R, Brentnall TA, Grady WM, Williams CS (2017) Gut 66(5): 852-862
    › Primary publication · 28389570 (PubMed) · PMC5385850 (PubMed Central)
  9. Three-dimensional culture system identifies a new mode of cetuximab resistance and disease-relevant genes in colorectal cancer. Li C, Singh B, Graves-Deal R, Ma H, Starchenko A, Fry WH, Lu Y, Wang Y, Bogatcheva G, Khan MP, Milne GL, Zhao S, Ayers GD, Li N, Hu H, Washington MK, Yeatman TJ, McDonald OG, Liu Q, Coffey RJ (2017) Proc Natl Acad Sci U S A 114(14): E2852-E2861
    › Primary publication · 28320945 (PubMed) · PMC5389279 (PubMed Central)
  10. EGFR-mediated macrophage activation promotes colitis-associated tumorigenesis. Hardbower DM, Coburn LA, Asim M, Singh K, Sierra JC, Barry DP, Gobert AP, Piazuelo MB, Washington MK, Wilson KT (2017) Oncogene 36(27): 3807-3819
    › Primary publication · 28263971 (PubMed) · PMC5501754 (PubMed Central)
  11. Factors Associated With Persistent Increase in Level of Alanine Aminotransferase in Patients With Chronic Hepatitis B Receiving Oral Antiviral Therapy. Jacobson IM, Washington MK, Buti M, Thompson A, Afdhal N, Flisiak R, Akarca US, Tchernev KG, Flaherty JF, Aguilar Schall R, Myers RP, Subramanian GM, McHutchison JG, Younossi Z, Marcellin P, Patel K (2017) Clin Gastroenterol Hepatol 15(7): 1087-1094.e2
    › Primary publication · 28215615 (PubMed)
  12. HER2 Testing and Clinical Decision Making in Gastroesophageal Adenocarcinoma: Guideline From the College of American Pathologists, American Society for Clinical Pathology, and the American Society of Clinical Oncology. Bartley AN, Washington MK, Colasacco C, Ventura CB, Ismaila N, Benson AB, Carrato A, Gulley ML, Jain D, Kakar S, Mackay HJ, Streutker C, Tang L, Troxell M, Ajani JA (2017) J Clin Oncol 35(4): 446-464
    › Primary publication · 28129524 (PubMed)
  13. HER2 Testing and Clinical Decision Making in Gastroesophageal Adenocarcinoma: Guideline From the College of American Pathologists, American Society for Clinical Pathology, and American Society of Clinical Oncology. Bartley AN, Washington MK, Ventura CB, Ismaila N, Colasacco C, Benson AB, Carrato A, Gulley ML, Jain D, Kakar S, Mackay HJ, Streutker C, Tang L, Troxell M, Ajani JA (2016) Am J Clin Pathol 146(6): 647-669
    › Primary publication · 28077399 (PubMed) · PMC6272805 (PubMed Central)
  14. HER2 Testing and Clinical Decision Making in Gastroesophageal Adenocarcinoma: Guideline Summary From the College of American Pathologists, American Society for Clinical Pathology, and American Society of Clinical Oncology. Bartley AN, Washington MK, Ismaila N, Ajani JA (2017) J Oncol Pract 13(1): 53-57
    › Primary publication · 27907277 (PubMed)
  15. HER2 Testing and Clinical Decision Making in Gastroesophageal Adenocarcinoma: Guideline From the College of American Pathologists, American Society for Clinical Pathology, and American Society of Clinical Oncology. Bartley AN, Washington MK, Ventura CB, Ismaila N, Colasacco C, Benson AB, Carrato A, Gulley ML, Jain D, Kakar S, Mackay HJ, Streutker C, Tang L, Troxell M, Ajani JA (2016) Arch Pathol Lab Med 140(12): 1345-1363
    › Primary publication · 27841667 (PubMed)
  16. Non-Invasive Glutamine PET Reflects Pharmacological Inhibition of BRAF In Vivo. Schulte ML, Hight MR, Ayers GD, Liu Q, Shyr Y, Washington MK, Manning HC (2017) Mol Imaging Biol 19(3): 421-428
    › Primary publication · 27770401 (PubMed) · PMC6476310 (PubMed Central)
  17. Impaired coordination between signaling pathways is revealed in human colorectal cancer using single-cell mass cytometry of archival tissue blocks. Simmons AJ, Scurrah CR, McKinley ET, Herring CA, Irish JM, Washington MK, Coffey RJ, Lau KS (2016) Sci Signal 9(449): rs11
    › Primary publication · 27729552 (PubMed) · PMC5111815 (PubMed Central)
  18. The Spectrum of Histologic Findings in Hepatic Outflow Obstruction. Gonzalez RS, Gilger MA, Huh WJ, Washington MK (2017) Arch Pathol Lab Med 141(1): 98-103
    › Primary publication · 27681331 (PubMed) · PMC6420777 (PubMed Central)
  19. Utility of [F]FSPG PET to Image Hepatocellular Carcinoma: First Clinical Evaluation in a US Population. Kavanaugh G, Williams J, Morris AS, Nickels ML, Walker R, Koglin N, Stephens AW, Washington MK, Geevarghese SK, Liu Q, Ayers D, Shyr Y, Manning HC (2016) Mol Imaging Biol 18(6): 924-934
    › Primary publication · 27677886 (PubMed) · PMC5641676 (PubMed Central)
  20. Dietary zinc alters the microbiota and decreases resistance to Clostridium difficile infection. Zackular JP, Moore JL, Jordan AT, Juttukonda LJ, Noto MJ, Nicholson MR, Crews JD, Semler MW, Zhang Y, Ware LB, Washington MK, Chazin WJ, Caprioli RM, Skaar EP (2016) Nat Med 22(11): 1330-1334
    › Primary publication · 27668938 (PubMed) · PMC5101143 (PubMed Central)
  21. Prox1-Heterozygosis Sensitizes the Pancreas to Oncogenic Kras-Induced Neoplastic Transformation. Drosos Y, Neale G, Ye J, Paul L, Kuliyev E, Maitra A, Means AL, Washington MK, Rehg J, Finkelstein DB, Sosa-Pineda B (2016) Neoplasia 18(3): 172-84
    › Primary publication · 26992918 (PubMed) · PMC4796801 (PubMed Central)
  22. Western diet enhances benzo(a)pyrene-induced colon tumorigenesis in a polyposis in rat coli (PIRC) rat model of colon cancer. Harris KL, Pulliam SR, Okoro E, Guo Z, Washington MK, Adunyah SE, Amos-Landgraf JM, Ramesh A (2016) Oncotarget 7(20): 28947-60
    › Primary publication · 26959117 (PubMed) · PMC5045369 (PubMed Central)
  23. APE1-mediated DNA damage repair provides survival advantage for esophageal adenocarcinoma cells in response to acidic bile salts. Hong J, Chen Z, Peng D, Zaika A, Revetta F, Washington MK, Belkhiri A, El-Rifai W (2016) Oncotarget 7(13): 16688-702
    › Primary publication · 26934647 (PubMed) · PMC4941344 (PubMed Central)
  24. Advanced Intestinal Cancers often Maintain a Multi-Ancestral Architecture. Zahm CD, Szulczewski JM, Leystra AA, Paul Olson TJ, Clipson L, Albrecht DM, Middlebrooks M, Thliveris AT, Matkowskyj KA, Washington MK, Newton MA, Eliceiri KW, Halberg RB (2016) PLoS One 11(2): e0150170
    › Primary publication · 26919712 (PubMed) · PMC4769224 (PubMed Central)
  25. BVES Regulates Intestinal Stem Cell Programs and Intestinal Crypt Viability after Radiation. Reddy VK, Short SP, Barrett CW, Mittal MK, Keating CE, Thompson JJ, Harris EI, Revetta F, Bader DM, Brand T, Washington MK, Williams CS (2016) Stem Cells 34(6): 1626-36
    › Primary publication · 26891025 (PubMed) · PMC4893006 (PubMed Central)
  26. Olive oil prevents benzo(a)pyrene [B(a)P]-induced colon carcinogenesis through altered B(a)P metabolism and decreased oxidative damage in Apc(Min) mouse model. Banks LD, Amoah P, Niaz MS, Washington MK, Adunyah SE, Ramesh A (2016) J Nutr Biochem : 37-50
    › Primary publication · 26878781 (PubMed) · PMC4757813 (PubMed Central)
  27. Pathology of Gastrointestinal Neuroendocrine Tumors: An Update. Moreira RK, Washington K (2010) Surg Pathol Clin 3(2): 327-47
    › Primary publication · 26839134 (PubMed)
  28. Ménétrier's Disease: Its Mimickers and Pathogenesis. Huh WJ, Coffey RJ, Washington MK (2016) J Pathol Transl Med 50(1): 10-6
    › Primary publication · 26689786 (PubMed) · PMC4734964 (PubMed Central)
  29. The impact of stage, grade, and mucinous histology on the efficacy of systemic chemotherapy in adenocarcinomas of the appendix: Analysis of the National Cancer Data Base. Asare EA, Compton CC, Hanna NN, Kosinski LA, Washington MK, Kakar S, Weiser MR, Overman MJ (2016) Cancer 122(2): 213-21
    › Primary publication · 26506400 (PubMed) · PMC4860278 (PubMed Central)
  30. The Applicability of a Human Immunohistochemical Panel to Mouse Models of Hepatocellular Neoplasia. Salleng KJ, Revetta FL, Deane NG, Washington MK (2015) Comp Med 65(5): 398-408
    › Primary publication · 26473343 (PubMed) · PMC4617330 (PubMed Central)
  31. Pyruvate Kinase Muscle Isoenzyme 2 (PKM2) Expression Is Associated with Overall Survival in Pancreatic Ductal Adenocarcinoma. Lockney NA, Zhang M, Lu Y, Sopha SC, Washington MK, Merchant N, Zhao Z, Shyr Y, Chakravarthy AB, Xia F (2015) J Gastrointest Cancer 46(4): 390-8
    › Primary publication · 26385349 (PubMed) · PMC7081381 (PubMed Central)
  32. Trefoil factor 1 expression suppresses Helicobacter pylori-induced inflammation in gastric carcinogenesis. Soutto M, Chen Z, Katsha AM, Romero-Gallo J, Krishna US, Piazuelo MB, Washington MK, Peek RM, Belkhiri A, El-Rifai WM (2015) Cancer 121(24): 4348-58
    › Primary publication · 26372254 (PubMed) · PMC4670586 (PubMed Central)
  33. Consensus on biomarkers for neuroendocrine tumour disease. Oberg K, Modlin IM, De Herder W, Pavel M, Klimstra D, Frilling A, Metz DC, Heaney A, Kwekkeboom D, Strosberg J, Meyer T, Moss SF, Washington K, Wolin E, Liu E, Goldenring J (2015) Lancet Oncol 16(9): e435-e446
    › Primary publication · 26370353 (PubMed) · PMC5023063 (PubMed Central)
  34. IL-33 Signaling Protects from Murine Oxazolone Colitis by Supporting Intestinal Epithelial Function. Waddell A, Vallance JE, Moore PD, Hummel AT, Wu D, Shanmukhappa SK, Fei L, Washington MK, Minar P, Coburn LA, Nakae S, Wilson KT, Denson LA, Hogan SP, Rosen MJ (2015) Inflamm Bowel Dis 21(12): 2737-46
    › Primary publication · 26313694 (PubMed) · PMC4654638 (PubMed Central)
  35. Human Islets Have Fewer Blood Vessels than Mouse Islets and the Density of Islet Vascular Structures Is Increased in Type 2 Diabetes. Brissova M, Shostak A, Fligner CL, Revetta FL, Washington MK, Powers AC, Hull RL (2015) J Histochem Cytochem 63(8): 637-45
    › Primary publication · 26216139 (PubMed) · PMC4530394 (PubMed Central)
  36. Linking patient outcome to high throughput protein expression data identifies novel regulators of colorectal adenocarcinoma aggressiveness. French CL, Ye F, Revetta F, Zhang B, Coffey RJ, Washington MK, Deane NG, Beauchamp RD, Weaver AM (2015) F1000Res : 99
    › Primary publication · 26097693 (PubMed) · PMC4457132 (PubMed Central)
  37. Tumor Necrosis Factor Receptor 2 Restricts the Pathogenicity of CD8(+) T Cells in Mice With Colitis. Punit S, Dubé PE, Liu CY, Girish N, Washington MK, Polk DB (2015) Gastroenterology 149(4): 993-1005.e2
    › Primary publication · 26072395 (PubMed) · PMC4841683 (PubMed Central)
  38. Selenoprotein P influences colitis-induced tumorigenesis by mediating stemness and oxidative damage. Barrett CW, Reddy VK, Short SP, Motley AK, Lintel MK, Bradley AM, Freeman T, Vallance J, Ning W, Parang B, Poindexter SV, Fingleton B, Chen X, Washington MK, Wilson KT, Shroyer NF, Hill KE, Burk RF, Williams CS (2015) J Clin Invest 125(7): 2646-60
    › Primary publication · 26053663 (PubMed) · PMC4563672 (PubMed Central)
  39. Loss of TFF1 promotes Helicobacter pylori-induced β-catenin activation and gastric tumorigenesis. Soutto M, Romero-Gallo J, Krishna U, Piazuelo MB, Washington MK, Belkhiri A, Peek RM, El-Rifai W (2015) Oncotarget 6(20): 17911-22
    › Primary publication · 25980439 (PubMed) · PMC4627225 (PubMed Central)
  40. Improving the quality of cancer staging. Asare EA, Washington MK, Gress DM, Gershenwald JE, Greene FL (2015) CA Cancer J Clin 65(4): 261-3
    › Primary publication · 25952338 (PubMed)
  41. ERBB4 is over-expressed in human colon cancer and enhances cellular transformation. Williams CS, Bernard JK, Demory Beckler M, Almohazey D, Washington MK, Smith JJ, Frey MR (2015) Carcinogenesis 36(7): 710-8
    › Primary publication · 25916654 (PubMed) · PMC4572918 (PubMed Central)
  42. Adenoma-like adenocarcinoma: a subtype of colorectal carcinoma with good prognosis, deceptive appearance on biopsy and frequent KRAS mutation. Gonzalez RS, Cates JM, Washington MK, Beauchamp RD, Coffey RJ, Shi C (2016) Histopathology 68(2): 183-90
    › Primary publication · 25913616 (PubMed) · PMC4619179 (PubMed Central)
  43. [(18)F]-FLT PET to predict early response to neoadjuvant therapy in KRAS wild-type rectal cancer: a pilot study. McKinley ET, Watchmaker JM, Chakravarthy AB, Meyerhardt JA, Engelman JA, Walker RC, Washington MK, Coffey RJ, Manning HC (2015) Ann Nucl Med 29(6): 535-42
    › Primary publication · 25899481 (PubMed) · PMC4503488 (PubMed Central)
  44. Esophageal and esophagogastric junction cancers, version 1.2015. Ajani JA, D'Amico TA, Almhanna K, Bentrem DJ, Besh S, Chao J, Das P, Denlinger C, Fanta P, Fuchs CS, Gerdes H, Glasgow RE, Hayman JA, Hochwald S, Hofstetter WL, Ilson DH, Jaroszewski D, Jasperson K, Keswani RN, Kleinberg LR, Korn WM, Leong S, Lockhart AC, Mulcahy MF, Orringer MB, Posey JA, Poultsides GA, Sasson AR, Scott WJ, Strong VE, Varghese TK, Washington MK, Willett CG, Wright CD, Zelman D, McMillian N, Sundar H, National comprehensive cancer network (2015) J Natl Compr Canc Netw 13(2): 194-227
    › Primary publication · 25691612 (PubMed)
  45. Phosphotyrosine signaling analysis in human tumors is confounded by systemic ischemia-driven artifacts and intra-specimen heterogeneity. Gajadhar AS, Johnson H, Slebos RJ, Shaddox K, Wiles K, Washington MK, Herline AJ, Levine DA, Liebler DC, White FM, Clinical Proteomic Tumor Analysis Consortium (2015) Cancer Res 75(7): 1495-503
    › Primary publication · 25670172 (PubMed) · PMC4383696 (PubMed Central)
  46. NIH Consensus development project on criteria for clinical trials in chronic graft-versus-host disease: II. The 2014 Pathology Working Group Report. Shulman HM, Cardona DM, Greenson JK, Hingorani S, Horn T, Huber E, Kreft A, Longerich T, Morton T, Myerson D, Prieto VG, Rosenberg A, Treister N, Washington K, Ziemer M, Pavletic SZ, Lee SJ, Flowers ME, Schultz KR, Jagasia M, Martin PJ, Vogelsang GB, Kleiner DE (2015) Biol Blood Marrow Transplant 21(4): 589-603
    › Primary publication · 25639770 (PubMed) · PMC4359636 (PubMed Central)
  47. Biomarkers of NAFLD progression: a lipidomics approach to an epidemic. Gorden DL, Myers DS, Ivanova PT, Fahy E, Maurya MR, Gupta S, Min J, Spann NJ, McDonald JG, Kelly SL, Duan J, Sullards MC, Leiker TJ, Barkley RM, Quehenberger O, Armando AM, Milne SB, Mathews TP, Armstrong MD, Li C, Melvin WV, Clements RH, Washington MK, Mendonsa AM, Witztum JL, Guan Z, Glass CK, Murphy RC, Dennis EA, Merrill AH, Russell DW, Subramaniam S, Brown HA (2015) J Lipid Res 56(3): 722-736
    › Primary publication · 25598080 (PubMed) · PMC4340319 (PubMed Central)
  48. Transcriptional corepressor MTG16 regulates small intestinal crypt proliferation and crypt regeneration after radiation-induced injury. Poindexter SV, Reddy VK, Mittal MK, Williams AM, Washington MK, Harris E, Mah A, Hiebert SW, Singh K, Chaturvedi R, Wilson KT, Lund PK, Williams CS (2015) Am J Physiol Gastrointest Liver Physiol 308(6): G562-71
    › Primary publication · 25573176 (PubMed) · PMC4360050 (PubMed Central)
  49. Claudin-7 expression induces mesenchymal to epithelial transformation (MET) to inhibit colon tumorigenesis. Bhat AA, Pope JL, Smith JJ, Ahmad R, Chen X, Washington MK, Beauchamp RD, Singh AB, Dhawan P (2015) Oncogene 34(35): 4570-80
    › Primary publication · 25500541 (PubMed) · PMC4804637 (PubMed Central)
  50. Implementation of an error-reporting module within a biorepository IT application to enhance operations. Wiles KR, Washington MK (2014) Biopreserv Biobank 12(6): 365-73
    › Primary publication · 25496147 (PubMed) · PMC4346604 (PubMed Central)
  51. The transcriptional corepressor MTGR1 regulates intestinal secretory lineage allocation. Parang B, Rosenblatt D, Williams AD, Washington MK, Revetta F, Short SP, Reddy VK, Hunt A, Shroyer NF, Engel ME, Hiebert SW, Williams CS (2015) FASEB J 29(3): 786-95
    › Primary publication · 25398765 (PubMed) · PMC4763883 (PubMed Central)
  52. Nuclear factor of activated T-cell activity is associated with metastatic capacity in colon cancer. Tripathi MK, Deane NG, Zhu J, An H, Mima S, Wang X, Padmanabhan S, Shi Z, Prodduturi N, Ciombor KK, Chen X, Washington MK, Zhang B, Beauchamp RD (2014) Cancer Res 74(23): 6947-57
    › Primary publication · 25320007 (PubMed) · PMC4252979 (PubMed Central)
  53. Phospholipid ether analogs for the detection of colorectal tumors. Deming DA, Maher ME, Leystra AA, Grudzinski JP, Clipson L, Albrecht DM, Washington MK, Matkowskyj KA, Hall LT, Lubner SJ, Weichert JP, Halberg RB (2014) PLoS One 9(10): e109668
    › Primary publication · 25286226 (PubMed) · PMC4186834 (PubMed Central)
  54. Identification of pathologic features associated with "ulcerative colitis-like" Crohn's disease. James SD, Wise PE, Zuluaga-Toro T, Schwartz DA, Washington MK, Shi C (2014) World J Gastroenterol 20(36): 13139-45
    › Primary publication · 25278708 (PubMed) · PMC4177493 (PubMed Central)
  55. 3'-Deoxy-3'-[18F]-Fluorothymidine PET imaging reflects PI3K-mTOR-mediated pro-survival response to targeted therapy in colorectal cancer. McKinley ET, Zhao P, Coffey RJ, Washington MK, Manning HC (2014) PLoS One 9(9): e108193
    › Primary publication · 25247710 (PubMed) · PMC4172755 (PubMed Central)
  56. Concerted loss of TGFβ-mediated proliferation control and E-cadherin disrupts epithelial homeostasis and causes oral squamous cell carcinoma. Andl T, Le Bras GF, Richards NF, Allison GL, Loomans HA, Washington MK, Revetta F, Lee RK, Taylor C, Moses HL, Andl CD (2014) Carcinogenesis 35(11): 2602-10
    › Primary publication · 25233932 (PubMed) · PMC4216061 (PubMed Central)
  57. The impact of tumor deposits on colonic adenocarcinoma AJCC TNM staging and outcome. Jin M, Roth R, Rock JB, Washington MK, Lehman A, Frankel WL (2015) Am J Surg Pathol 39(1): 109-15
    › Primary publication · 25229767 (PubMed) · PMC4267920 (PubMed Central)
  58. Viral suppression and cirrhosis regression with tenofovir disoproxil fumarate in Asians with chronic hepatitis B. Tsai NC, Marcellin P, Buti M, Washington MK, Lee SS, Chan S, Trinh H, Flaherty JF, Kitrinos KM, Dinh P, Charuworn P, Subramanian GM, Gane E (2015) Dig Dis Sci 60(1): 260-8
    › Primary publication · 25179493 (PubMed)
  59. Activation of β-catenin signalling by TFF1 loss promotes cell proliferation and gastric tumorigenesis. Soutto M, Peng D, Katsha A, Chen Z, Piazuelo MB, Washington MK, Belkhiri A, Correa P, El-Rifai W (2015) Gut 64(7): 1028-39
    › Primary publication · 25107557 (PubMed) · PMC4320984 (PubMed Central)
  60. Systems modeling of the role of interleukin-21 in the maintenance of effector CD4+ T cell responses during chronic Helicobacter pylori infection. Carbo A, Olivares-Villagómez D, Hontecillas R, Bassaganya-Riera J, Chaturvedi R, Piazuelo MB, Delgado A, Washington MK, Wilson KT, Algood HM (2014) mBio 5(4): e01243-14
    › Primary publication · 25053783 (PubMed) · PMC4120195 (PubMed Central)
  61. Fluorescence-based endoscopic imaging of Thomsen-Friedenreich antigen to improve early detection of colorectal cancer. Sakuma S, Yu JY, Quang T, Hiwatari K, Kumagai H, Kao S, Holt A, Erskind J, McClure R, Siuta M, Kitamura T, Tobita E, Koike S, Wilson K, Richards-Kortum R, Liu E, Washington K, Omary R, Gore JC, Pham W (2015) Int J Cancer 136(5): 1095-103
    › Primary publication · 25052906 (PubMed) · PMC4268149 (PubMed Central)
  62. Claudin-1 overexpression in intestinal epithelial cells enhances susceptibility to adenamatous polyposis coli-mediated colon tumorigenesis. Pope JL, Ahmad R, Bhat AA, Washington MK, Singh AB, Dhawan P (2014) Mol Cancer : 167
    › Primary publication · 24997475 (PubMed) · PMC4105545 (PubMed Central)
  63. Controlled colonic insufflation by a remotely triggered capsule for improved mucosal visualization. Pasricha T, Smith BF, Mitchell VR, Fang B, Brooks ER, Gerding JS, Washington MK, Valdastri P, Obstein KL (2014) Endoscopy 46(7): 614-8
    › Primary publication · 24845802 (PubMed) · PMC7047728 (PubMed Central)
  64. Inducible loss of one Apc allele in Lrig1-expressing progenitor cells results in multiple distal colonic tumors with features of familial adenomatous polyposis. Powell AE, Vlacich G, Zhao ZY, McKinley ET, Washington MK, Manning HC, Coffey RJ (2014) Am J Physiol Gastrointest Liver Physiol 307(1): G16-23
    › Primary publication · 24833705 (PubMed) · PMC4080164 (PubMed Central)
  65. The effects of frozen tissue storage conditions on the integrity of RNA and protein. Auer H, Mobley JA, Ayers LW, Bowen J, Chuaqui RF, Johnson LA, Livolsi VA, Lubensky IA, McGarvey D, Monovich LC, Moskaluk CA, Rumpel CA, Sexton KC, Washington MK, Wiles KR, Grizzle WE, Ramirez NC (2014) Biotech Histochem 89(7): 518-28
    › Primary publication · 24799092 (PubMed) · PMC4213858 (PubMed Central)
  66. Excess PLAC8 promotes an unconventional ERK2-dependent EMT in colon cancer. Li C, Ma H, Wang Y, Cao Z, Graves-Deal R, Powell AE, Starchenko A, Ayers GD, Washington MK, Kamath V, Desai K, Gerdes MJ, Solnica-Krezel L, Coffey RJ (2014) J Clin Invest 124(5): 2172-87
    › Primary publication · 24691442 (PubMed) · PMC4001536 (PubMed Central)
  67. Targeted colonic claudin-2 expression renders resistance to epithelial injury, induces immune suppression, and protects from colitis. Ahmad R, Chaturvedi R, Olivares-Villagómez D, Habib T, Asim M, Shivesh P, Polk DB, Wilson KT, Washington MK, Van Kaer L, Dhawan P, Singh AB (2014) Mucosal Immunol 7(6): 1340-53
    › Primary publication · 24670427 (PubMed) · PMC4221190 (PubMed Central)
  68. A peptide-based positron emission tomography probe for in vivo detection of caspase activity in apoptotic cells. Hight MR, Cheung YY, Nickels ML, Dawson ES, Zhao P, Saleh S, Buck JR, Tang D, Washington MK, Coffey RJ, Manning HC (2014) Clin Cancer Res 20(8): 2126-35
    › Primary publication · 24573549 (PubMed) · PMC3989451 (PubMed Central)
  69. Fibrogenesis in pancreatic cancer is a dynamic process regulated by macrophage-stellate cell interaction. Shi C, Washington MK, Chaturvedi R, Drosos Y, Revetta FL, Weaver CJ, Buzhardt E, Yull FE, Blackwell TS, Sosa-Pineda B, Whitehead RH, Beauchamp RD, Wilson KT, Means AL (2014) Lab Invest 94(4): 409-21
    › Primary publication · 24535260 (PubMed) · PMC3992484 (PubMed Central)
  70. Activation of EGFR and ERBB2 by Helicobacter pylori results in survival of gastric epithelial cells with DNA damage. Chaturvedi R, Asim M, Piazuelo MB, Yan F, Barry DP, Sierra JC, Delgado AG, Hill S, Casero RA, Bravo LE, Dominguez RL, Correa P, Polk DB, Washington MK, Rose KL, Schey KL, Morgan DR, Peek RM, Wilson KT (2014) Gastroenterology 146(7): 1739-51.e14
    › Primary publication · 24530706 (PubMed) · PMC4035375 (PubMed Central)
  71. Novel mechanistic insights into ectodomain shedding of EGFR Ligands Amphiregulin and TGF-α: impact on gastrointestinal cancers driven by secondary bile acids. Nagathihalli NS, Beesetty Y, Lee W, Washington MK, Chen X, Lockhart AC, Merchant NB (2014) Cancer Res 74(7): 2062-72
    › Primary publication · 24520077 (PubMed) · PMC3975694 (PubMed Central)
  72. Checklists, protocols, and the "gold standard" approach. Washington MK, Baker TP, Simpson J (2014) Arch Pathol Lab Med 138(2): 159-60
    › Primary publication · 24476515 (PubMed)
  73. Should mesenteric tumor deposits be included in staging of well-differentiated small intestine neuroendocrine tumors? Gonzalez RS, Liu EH, Alvarez JR, Ayers GD, Washington MK, Shi C (2014) Mod Pathol 27(9): 1288-95
    › Primary publication · 24457461 (PubMed) · PMC4110189 (PubMed Central)
  74. Tumor deposits in rectal adenocarcinoma after neoadjuvant chemoradiation are associated with poor prognosis. Gopal P, Lu P, Ayers GD, Herline AJ, Washington MK (2014) Mod Pathol 27(9): 1281-7
    › Primary publication · 24434897 (PubMed) · PMC4230335 (PubMed Central)
  75. Activation of the epidermal growth factor receptor in macrophages regulates cytokine production and experimental colitis. Lu N, Wang L, Cao H, Liu L, Van Kaer L, Washington MK, Rosen MJ, Dubé PE, Wilson KT, Ren X, Hao X, Polk DB, Yan F (2014) J Immunol 192(3): 1013-23
    › Primary publication · 24391216 (PubMed) · PMC4006992 (PubMed Central)
  76. Loss of Smad4 in colorectal cancer induces resistance to 5-fluorouracil through activating Akt pathway. Zhang B, Zhang B, Chen X, Bae S, Singh K, Washington MK, Datta PK (2014) Br J Cancer 110(4): 946-57
    › Primary publication · 24384683 (PubMed) · PMC3929873 (PubMed Central)
  77. Endoscopic mucosal resection of Barrett's esophagus detects high prevalence of subsquamous intestinal metaplasia. Yachimski P, Shi C, Slaughter JC, Washington MK (2013) World J Gastrointest Endosc 5(12): 590-4
    › Primary publication · 24368934 (PubMed) · PMC3870912 (PubMed Central)
  78. Diagnostic and therapeutic implications of a novel immunohistochemical panel detecting duodenal mucosal invasion by pancreatic ductal adenocarcinoma. Sopha SC, Gopal P, Merchant NB, Revetta FL, Gold DV, Washington K, Shi C (2013) Int J Clin Exp Pathol 6(11): 2476-86
    › Primary publication · 24228110 (PubMed) · PMC3816817 (PubMed Central)
  79. Standardization of pathology reports for rectal cancer: are we there yet? Berho M, Washington K (2013) Dis Colon Rectum 56(12): 1438-42
    › Primary publication · 24201400 (PubMed)
  80. Epidermal growth factor receptor signaling pathway is frequently altered in ampullary carcinoma at protein and genetic levels. Mikhitarian K, Pollen M, Zhao Z, Shyr Y, Merchant NB, Parikh A, Revetta F, Washington MK, Vnencak-Jones C, Shi C (2014) Mod Pathol 27(5): 665-74
    › Primary publication · 24186143 (PubMed) · PMC4007414 (PubMed Central)
  81. Malignant transformation of colonic epithelial cells by a colon-derived long noncoding RNA. Franklin JL, Rankin CR, Levy S, Snoddy JR, Zhang B, Washington MK, Thomson JM, Whitehead RH, Coffey RJ (2013) Biochem Biophys Res Commun 440(1): 99-104
    › Primary publication · 24045012 (PubMed) · PMC3875348 (PubMed Central)
  82. Identification and manipulation of biliary metaplasia in pancreatic tumors. Delgiorno KE, Hall JC, Takeuchi KK, Pan FC, Halbrook CJ, Washington MK, Olive KP, Spence JR, Sipos B, Wright CV, Wells JM, Crawford HC (2014) Gastroenterology 146(1): 233-44.e5
    › Primary publication · 23999170 (PubMed) · PMC3870045 (PubMed Central)
  83. Aurora kinase A promotes inflammation and tumorigenesis in mice and human gastric neoplasia. Katsha A, Soutto M, Sehdev V, Peng D, Washington MK, Piazuelo MB, Tantawy MN, Manning HC, Lu P, Shyr Y, Ecsedy J, Belkhiri A, El-Rifai W (2013) Gastroenterology 145(6): 1312-22.e1-8
    › Primary publication · 23993973 (PubMed) · PMC3840093 (PubMed Central)
  84. A call to standardize preanalytic data elements for biospecimens. Robb JA, Gulley ML, Fitzgibbons PL, Kennedy MF, Cosentino LM, Washington K, Dash RC, Branton PA, Jewell SD, Lapham RL (2014) Arch Pathol Lab Med 138(4): 526-37
    › Primary publication · 23937609 (PubMed) · PMC6446924 (PubMed Central)
  85. Four jointed box 1 promotes angiogenesis and is associated with poor patient survival in colorectal carcinoma. Al-Greene NT, Means AL, Lu P, Jiang A, Schmidt CR, Chakravarthy AB, Merchant NB, Washington MK, Zhang B, Shyr Y, Deane NG, Beauchamp RD (2013) PLoS One 8(7): e69660
    › Primary publication · 23922772 (PubMed) · PMC3726759 (PubMed Central)
  86. Debating deposits: an interobserver variability study of lymph nodes and pericolonic tumor deposits in colonic adenocarcinoma. Rock JB, Washington MK, Adsay NV, Greenson JK, Montgomery EA, Robert ME, Yantiss RK, Lehman AM, Frankel WL (2014) Arch Pathol Lab Med 138(5): 636-42
    › Primary publication · 23902577 (PubMed) · PMC3935980 (PubMed Central)
  87. Data set for reporting of lung carcinomas: recommendations from International Collaboration on Cancer Reporting. Jones KD, Churg A, Henderson DW, Hwang DM, Ma Wyatt J, Nicholson AG, Rice AJ, Washington MK, Butnor KJ (2013) Arch Pathol Lab Med 137(8): 1054-62
    › Primary publication · 23899061 (PubMed)
  88. Dietary selenium deficiency exacerbates DSS-induced epithelial injury and AOM/DSS-induced tumorigenesis. Barrett CW, Singh K, Motley AK, Lintel MK, Matafonova E, Bradley AM, Ning W, Poindexter SV, Parang B, Reddy VK, Chaturvedi R, Fingleton BM, Washington MK, Wilson KT, Davies SS, Hill KE, Burk RF, Williams CS (2013) PLoS One 8(7): e67845
    › Primary publication · 23861820 (PubMed) · PMC3701622 (PubMed Central)
  89. Pattern of breast cancer susceptibility gene 1 expression is a potential prognostic biomarker in resectable pancreatic ductal adenocarcinoma. Wang T, Wentz SC, Ausborn NL, Washington MK, Merchant N, Zhao Z, Shyr Y, Chakravarthy AB, Xia F (2013) Pancreas 42(6): 977-82
    › Primary publication · 23851432 (PubMed) · PMC4026161 (PubMed Central)
  90. Transformation of epithelial cells through recruitment leads to polyclonal intestinal tumors. Thliveris AT, Schwefel B, Clipson L, Plesh L, Zahm CD, Leystra AA, Washington MK, Sullivan R, Deming DA, Newton MA, Halberg RB (2013) Proc Natl Acad Sci U S A 110(28): 11523-8
    › Primary publication · 23798428 (PubMed) · PMC3710880 (PubMed Central)
  91. Claudin-1 regulates intestinal epithelial homeostasis through the modulation of Notch-signalling. Pope JL, Bhat AA, Sharma A, Ahmad R, Krishnan M, Washington MK, Beauchamp RD, Singh AB, Dhawan P (2014) Gut 63(4): 622-34
    › Primary publication · 23766441 (PubMed) · PMC4083824 (PubMed Central)
  92. Deciphering the unique microRNA signature in human esophageal adenocarcinoma. Saad R, Chen Z, Zhu S, Jia P, Zhao Z, Washington MK, Belkhiri A, El-Rifai W (2013) PLoS One 8(5): e64463
    › Primary publication · 23724052 (PubMed) · PMC3665888 (PubMed Central)
  93. Proinflammatory cytokines and bile acids upregulate ΔNp73 protein, an inhibitor of p53 and p73 tumor suppressors. Zaika E, Bhardwaj V, Wei J, Washington MK, Souza R, El-Rifai W, Zaika A (2013) PLoS One 8(5): e64306
    › Primary publication · 23717592 (PubMed) · PMC3661465 (PubMed Central)
  94. PIK3CA and APC mutations are synergistic in the development of intestinal cancers. Deming DA, Leystra AA, Nettekoven L, Sievers C, Miller D, Middlebrooks M, Clipson L, Albrecht D, Bacher J, Washington MK, Weichert J, Halberg RB (2014) Oncogene 33(17): 2245-54
    › Primary publication · 23708654 (PubMed) · PMC3883937 (PubMed Central)
  95. Deletion of cationic amino acid transporter 2 exacerbates dextran sulfate sodium colitis and leads to an IL-17-predominant T cell response. Singh K, Coburn LA, Barry DP, Asim M, Scull BP, Allaman MM, Lewis ND, Washington MK, Rosen MJ, Williams CS, Chaturvedi R, Wilson KT (2013) Am J Physiol Gastrointest Liver Physiol 305(3): G225-40
    › Primary publication · 23703655 (PubMed) · PMC3742860 (PubMed Central)
  96. Transformation of polarized epithelial cells by apical mistrafficking of epiregulin. Singh B, Bogatcheva G, Washington MK, Coffey RJ (2013) Proc Natl Acad Sci U S A 110(22): 8960-5
    › Primary publication · 23671122 (PubMed) · PMC3670353 (PubMed Central)
  97. Gastric cancer, version 2.2013: featured updates to the NCCN Guidelines. Ajani JA, Bentrem DJ, Besh S, D'Amico TA, Das P, Denlinger C, Fakih MG, Fuchs CS, Gerdes H, Glasgow RE, Hayman JA, Hofstetter WL, Ilson DH, Keswani RN, Kleinberg LR, Korn WM, Lockhart AC, Meredith K, Mulcahy MF, Orringer MB, Posey JA, Sasson AR, Scott WJ, Strong VE, Varghese TK, Warren G, Washington MK, Willett C, Wright CD, McMillian NR, Sundar H, National Comprehensive Cancer Network (2013) J Natl Compr Canc Netw 11(5): 531-46
    › Primary publication · 23667204 (PubMed)
  98. mTOR inhibition elicits a dramatic response in PI3K-dependent colon cancers. Deming DA, Leystra AA, Farhoud M, Nettekoven L, Clipson L, Albrecht D, Washington MK, Sullivan R, Weichert JP, Halberg RB (2013) PLoS One 8(4): e60709
    › Primary publication · 23593290 (PubMed) · PMC3621889 (PubMed Central)
  99. High dietary salt intake exacerbates Helicobacter pylori-induced gastric carcinogenesis. Gaddy JA, Radin JN, Loh JT, Zhang F, Washington MK, Peek RM, Algood HM, Cover TL (2013) Infect Immun 81(6): 2258-67
    › Primary publication · 23569116 (PubMed) · PMC3676043 (PubMed Central)
  100. Limits of [18F]-FLT PET as a biomarker of proliferation in oncology. McKinley ET, Ayers GD, Smith RA, Saleh SA, Zhao P, Washington MK, Coffey RJ, Manning HC (2013) PLoS One 8(3): e58938
    › Primary publication · 23554961 (PubMed) · PMC3598948 (PubMed Central)
  101. Elevated ALCAM shedding in colorectal cancer correlates with poor patient outcome. Hansen AG, Freeman TJ, Arnold SA, Starchenko A, Jones-Paris CR, Gilger MA, Washington MK, Fan KH, Shyr Y, Beauchamp RD, Zijlstra A (2013) Cancer Res 73(10): 2955-64
    › Primary publication · 23539446 (PubMed) · PMC3660148 (PubMed Central)
  102. The interleukin-17 receptor B subunit is essential for the Th2 response to Helicobacter pylori, but not for control of bacterial burden. Horvath DJ, Radin JN, Cho SH, Washington MK, Algood HM (2013) PLoS One 8(3): e60363
    › Primary publication · 23533678 (PubMed) · PMC3606319 (PubMed Central)
  103. 53BP1 expression is a modifier of the prognostic value of lymph node ratio and CA 19-9 in pancreatic adenocarcinoma. Ausborn NL, Wang T, Wentz SC, Washington MK, Merchant NB, Zhao Z, Shyr Y, Chakravarthy AB, Xia F (2013) BMC Cancer : 155
    › Primary publication · 23530749 (PubMed) · PMC3636043 (PubMed Central)
  104. Gastric adenocarcinoma has a unique microRNA signature not present in esophageal adenocarcinoma. Chen Z, Saad R, Jia P, Peng D, Zhu S, Washington MK, Zhao Z, Xu Z, El-Rifai W (2013) Cancer 119(11): 1985-93
    › Primary publication · 23456798 (PubMed) · PMC3731210 (PubMed Central)
  105. Lymph node ratio and preoperative CA 19-9 levels predict overall survival and recurrence-free survival in patients with resected pancreatic adenocarcinoma. Wentz SC, Zhao ZG, Shyr Y, Shi CJ, Merchant NB, Washington K, Xia F, Chakravarthy AB (2012) World J Gastrointest Oncol 4(10): 207-15
    › Primary publication · 23444312 (PubMed) · PMC3581835 (PubMed Central)
  106. Pathology of rodent models of intestinal cancer: progress report and recommendations. Washington MK, Powell AE, Sullivan R, Sundberg JP, Wright N, Coffey RJ, Dove WF (2013) Gastroenterology 144(4): 705-17
    › Primary publication · 23415801 (PubMed) · PMC3660997 (PubMed Central)
  107. Expert pathology review and endoscopic mucosal resection alters the diagnosis of patients referred to undergo therapy for Barrett's esophagus. Ayers K, Shi C, Washington K, Yachimski P (2013) Surg Endosc 27(8): 2836-40
    › Primary publication · 23389078 (PubMed) · PMC6444893 (PubMed Central)
  108. Proteomic patterns of colonic mucosal tissues delineate Crohn's colitis and ulcerative colitis. Seeley EH, Washington MK, Caprioli RM, M'Koma AE (2013) Proteomics Clin Appl 7(7-8): 541-9
    › Primary publication · 23382084 (PubMed) · PMC3737405 (PubMed Central)
  109. Heparin-binding epidermal growth factor-like growth factor eliminates constraints on activated Kras to promote rapid onset of pancreatic neoplasia. Ray KC, Moss ME, Franklin JL, Weaver CJ, Higginbotham J, Song Y, Revetta FL, Blaine SA, Bridges LR, Guess KE, Coffey RJ, Crawford HC, Washington MK, Means AL (2014) Oncogene 33(7): 823-31
    › Primary publication · 23376846 (PubMed) · PMC3929321 (PubMed Central)
  110. SPDEF functions as a colorectal tumor suppressor by inhibiting β-catenin activity. Noah TK, Lo YH, Price A, Chen G, King E, Washington MK, Aronow BJ, Shroyer NF (2013) Gastroenterology 144(5): 1012-1023.e6
    › Primary publication · 23376423 (PubMed) · PMC3738069 (PubMed Central)
  111. 3'-Deoxy-3'-18F-fluorothymidine PET predicts response to (V600E)BRAF-targeted therapy in preclinical models of colorectal cancer. McKinley ET, Smith RA, Zhao P, Fu A, Saleh SA, Uddin MI, Washington MK, Coffey RJ, Manning HC (2013) J Nucl Med 54(3): 424-30
    › Primary publication · 23341544 (PubMed) · PMC3633462 (PubMed Central)
  112. STAT6 deficiency ameliorates severity of oxazolone colitis by decreasing expression of claudin-2 and Th2-inducing cytokines. Rosen MJ, Chaturvedi R, Washington MK, Kuhnhein LA, Moore PD, Coggeshall SS, McDonough EM, Weitkamp JH, Singh AB, Coburn LA, Williams CS, Yan F, Van Kaer L, Peebles RS, Wilson KT (2013) J Immunol 190(4): 1849-58
    › Primary publication · 23303670 (PubMed) · PMC3563924 (PubMed Central)
  113. Regression of cirrhosis during treatment with tenofovir disoproxil fumarate for chronic hepatitis B: a 5-year open-label follow-up study. Marcellin P, Gane E, Buti M, Afdhal N, Sievert W, Jacobson IM, Washington MK, Germanidis G, Flaherty JF, Aguilar Schall R, Bornstein JD, Kitrinos KM, Subramanian GM, McHutchison JG, Heathcote EJ (2013) Lancet 381(9865): 468-75
    › Primary publication · 23234725 (PubMed)
  114. Tumor suppressor function of the plasma glutathione peroxidase gpx3 in colitis-associated carcinoma. Barrett CW, Ning W, Chen X, Smith JJ, Washington MK, Hill KE, Coburn LA, Peek RM, Chaturvedi R, Wilson KT, Burk RF, Williams CS (2013) Cancer Res 73(3): 1245-55
    › Primary publication · 23221387 (PubMed) · PMC3563732 (PubMed Central)
  115. Human epididymis protein 4 is up-regulated in gastric and pancreatic adenocarcinomas. O'Neal RL, Nam KT, LaFleur BJ, Barlow B, Nozaki K, Lee HJ, Kim WH, Yang HK, Shi C, Maitra A, Montgomery E, Washington MK, El Rifai W, Drapkin RI, Goldenring JR (2013) Hum Pathol 44(5): 734-42
    › Primary publication · 23084584 (PubMed) · PMC3556378 (PubMed Central)
  116. Neuregulin-4 is a survival factor for colon epithelial cells both in culture and in vivo. Bernard JK, McCann SP, Bhardwaj V, Washington MK, Frey MR (2012) J Biol Chem 287(47): 39850-8
    › Primary publication · 23033483 (PubMed) · PMC3501086 (PubMed Central)
  117. EGF receptor is required for KRAS-induced pancreatic tumorigenesis. Ardito CM, Grüner BM, Takeuchi KK, Lubeseder-Martellato C, Teichmann N, Mazur PK, Delgiorno KE, Carpenter ES, Halbrook CJ, Hall JC, Pal D, Briel T, Herner A, Trajkovic-Arsic M, Sipos B, Liou GY, Storz P, Murray NR, Threadgill DW, Sibilia M, Washington MK, Wilson CL, Schmid RM, Raines EW, Crawford HC, Siveke JT (2012) Cancer Cell 22(3): 304-17
    › Primary publication · 22975374 (PubMed) · PMC3443395 (PubMed Central)
  118. MTG16 contributes to colonic epithelial integrity in experimental colitis. Williams CS, Bradley AM, Chaturvedi R, Singh K, Piazuelo MB, Chen X, McDonough EM, Schwartz DA, Brown CT, Allaman MM, Coburn LA, Horst SN, Beaulieu DB, Choksi YA, Washington MK, Williams AD, Fisher MA, Zinkel SS, Peek RM, Wilson KT, Hiebert SW (2013) Gut 62(10): 1446-55
    › Primary publication · 22833394 (PubMed) · PMC3663894 (PubMed Central)
  119. [18F]FLT-PET to predict pharmacodynamic and clinical response to cetuximab therapy in Ménétrier's disease. McKinley ET, Smith RA, Tanksley JP, Washington MK, Walker R, Coffey RJ, Manning HC (2012) Ann Nucl Med 26(9): 757-63
    › Primary publication · 22821337 (PubMed) · PMC3543701 (PubMed Central)
  120. Caudal homeobox protein Cdx-2 cooperates with Wnt pathway to regulate claudin-1 expression in colon cancer cells. Bhat AA, Sharma A, Pope J, Krishnan M, Washington MK, Singh AB, Dhawan P (2012) PLoS One 7(6): e37174
    › Primary publication · 22719836 (PubMed) · PMC3376107 (PubMed Central)
  121. Molecular testing in colorectal cancer: diagnosis of Lynch syndrome and personalized cancer medicine. Shi C, Washington K (2012) Am J Clin Pathol 137(6): 847-59
    › Primary publication · 22586043 (PubMed)
  122. IL-23 Contributes to Control of Chronic Helicobacter Pylori Infection and the Development of T Helper Responses in a Mouse Model. Horvath DJ, Washington MK, Cope VA, Algood HM (2012) Front Immunol : 56
    › Primary publication · 22566937 (PubMed) · PMC3342083 (PubMed Central)
  123. Precision of multiple reaction monitoring mass spectrometry analysis of formalin-fixed, paraffin-embedded tissue. Sprung RW, Martinez MA, Carpenter KL, Ham AJ, Washington MK, Arteaga CL, Sanders ME, Liebler DC (2012) J Proteome Res 11(6): 3498-505
    › Primary publication · 22530795 (PubMed) · PMC3368395 (PubMed Central)
  124. Mice expressing activated PI3K rapidly develop advanced colon cancer. Leystra AA, Deming DA, Zahm CD, Farhoud M, Olson TJ, Hadac JN, Nettekoven LA, Albrecht DM, Clipson L, Sullivan R, Washington MK, Torrealba JR, Weichert JP, Halberg RB (2012) Cancer Res 72(12): 2931-6
    › Primary publication · 22525701 (PubMed) · PMC3645915 (PubMed Central)
  125. The pan-ErbB negative regulator Lrig1 is an intestinal stem cell marker that functions as a tumor suppressor. Powell AE, Wang Y, Li Y, Poulin EJ, Means AL, Washington MK, Higginbotham JN, Juchheim A, Prasad N, Levy SE, Guo Y, Shyr Y, Aronow BJ, Haigis KM, Franklin JL, Coffey RJ (2012) Cell 149(1): 146-58
    › Primary publication · 22464327 (PubMed) · PMC3563328 (PubMed Central)
  126. L-arginine supplementation improves responses to injury and inflammation in dextran sulfate sodium colitis. Coburn LA, Gong X, Singh K, Asim M, Scull BP, Allaman MM, Williams CS, Rosen MJ, Washington MK, Barry DP, Piazuelo MB, Casero RA, Chaturvedi R, Zhao Z, Wilson KT (2012) PLoS One 7(3): e33546
    › Primary publication · 22428068 (PubMed) · PMC3299802 (PubMed Central)
  127. The aurora kinase A inhibitor MLN8237 enhances cisplatin-induced cell death in esophageal adenocarcinoma cells. Sehdev V, Peng D, Soutto M, Washington MK, Revetta F, Ecsedy J, Zaika A, Rau TT, Schneider-Stock R, Belkhiri A, El-Rifai W (2012) Mol Cancer Ther 11(3): 763-74
    › Primary publication · 22302096 (PubMed) · PMC3297687 (PubMed Central)
  128. Dynamic distribution of claudin proteins in pancreatic epithelia undergoing morphogenesis or neoplastic transformation. Westmoreland JJ, Drosos Y, Kelly J, Ye J, Means AL, Washington MK, Sosa-Pineda B (2012) Dev Dyn 241(3): 583-94
    › Primary publication · 22275141 (PubMed) · PMC3288608 (PubMed Central)
  129. Berberine promotes recovery of colitis and inhibits inflammatory responses in colonic macrophages and epithelial cells in DSS-treated mice. Yan F, Wang L, Shi Y, Cao H, Liu L, Washington MK, Chaturvedi R, Israel DA, Cao H, Wang B, Peek RM, Wilson KT, Polk DB (2012) Am J Physiol Gastrointest Liver Physiol 302(5): G504-14
    › Primary publication · 22173918 (PubMed) · PMC3311435 (PubMed Central)
  130. ErbB2 and ErbB3 regulate recovery from dextran sulfate sodium-induced colitis by promoting mouse colon epithelial cell survival. Zhang Y, Dubé PE, Washington MK, Yan F, Polk DB (2012) Lab Invest 92(3): 437-50
    › Primary publication · 22157714 (PubMed) · PMC3289719 (PubMed Central)
  131. DNA methylation profiling in Barrett's esophagus and esophageal adenocarcinoma reveals unique methylation signatures and molecular subclasses. Kaz AM, Wong CJ, Luo Y, Virgin JB, Washington MK, Willis JE, Leidner RS, Chak A, Grady WM (2011) Epigenetics 6(12): 1403-12
    › Primary publication · 22139570 (PubMed) · PMC3256330 (PubMed Central)
  132. Smad4-mediated signaling inhibits intestinal neoplasia by inhibiting expression of β-catenin. Freeman TJ, Smith JJ, Chen X, Washington MK, Roland JT, Means AL, Eschrich SA, Yeatman TJ, Deane NG, Beauchamp RD (2012) Gastroenterology 142(3): 562-571.e2
    › Primary publication · 22115830 (PubMed) · PMC3343368 (PubMed Central)
  133. Targeting notch pathway enhances rapamycin antitumor activity in pancreas cancers through PTEN phosphorylation. Vo K, Amarasinghe B, Washington K, Gonzalez A, Berlin J, Dang TP (2011) Mol Cancer : 138
    › Primary publication · 22074495 (PubMed) · PMC3253061 (PubMed Central)
  134. CD44 upregulation in E-cadherin-negative esophageal cancers results in cell invasion. Le Bras GF, Allison GL, Richards NF, Ansari SS, Washington MK, Andl CD (2011) PLoS One 6(11): e27063
    › Primary publication · 22069487 (PubMed) · PMC3206075 (PubMed Central)
  135. BVES regulates EMT in human corneal and colon cancer cells and is silenced via promoter methylation in human colorectal carcinoma. Williams CS, Zhang B, Smith JJ, Jayagopal A, Barrett CW, Pino C, Russ P, Presley SH, Peng D, Rosenblatt DO, Haselton FR, Yang JL, Washington MK, Chen X, Eschrich S, Yeatman TJ, El-Rifai W, Beauchamp RD, Chang MS (2011) J Clin Invest 121(10): 4056-69
    › Primary publication · 21911938 (PubMed) · PMC3195453 (PubMed Central)
  136. Endoscopic therapy of esophageal premalignancy and early malignancy. Nealis TB, Washington K, Keswani RN (2011) J Natl Compr Canc Netw 9(8): 890-9
    › Primary publication · 21900219 (PubMed)
  137. Esophageal and esophagogastric junction cancers. Ajani JA, Barthel JS, Bentrem DJ, D'Amico TA, Das P, Denlinger CS, Fuchs CS, Gerdes H, Glasgow RE, Hayman JA, Hofstetter WL, Ilson DH, Keswani RN, Kleinberg LR, Korn WM, Lockhart AC, Mulcahy MF, Orringer MB, Osarogiagbon RU, Posey JA, Sasson AR, Scott WJ, Shibata S, Strong VE, Varghese TK, Warren G, Washington MK, Willett C, Wright CD, National Comprehensive Cancer Network (2011) J Natl Compr Canc Netw 9(8): 830-87
    › Primary publication · 21900218 (PubMed)
  138. Claudin-1 up-regulates the repressor ZEB-1 to inhibit E-cadherin expression in colon cancer cells. Singh AB, Sharma A, Smith JJ, Krishnan M, Chen X, Eschrich S, Washington MK, Yeatman TJ, Beauchamp RD, Dhawan P (2011) Gastroenterology 141(6): 2140-53
    › Primary publication · 21878201 (PubMed) · PMC3395068 (PubMed Central)
  139. Location-specific epigenetic regulation of the metallothionein 3 gene in esophageal adenocarcinomas. Peng D, Hu TL, Jiang A, Washington MK, Moskaluk CA, Schneider-Stock R, El-Rifai W (2011) PLoS One 6(7): e22009
    › Primary publication · 21818286 (PubMed) · PMC3139601 (PubMed Central)
  140. Organic anion transporting polypeptide 1B3 (OATP1B3) is overexpressed in colorectal tumors and is a predictor of clinical outcome. Lockhart AC, Harris E, Lafleur BJ, Merchant NB, Washington MK, Resnick MB, Yeatman TJ, Lee W (2008) Clin Exp Gastroenterol : 1-7
    › Primary publication · 21677819 (PubMed) · PMC3108628 (PubMed Central)
  141. Adenoma formation following limited ablation of p120-catenin in the mouse intestine. Smalley-Freed WG, Efimov A, Short SP, Jia P, Zhao Z, Washington MK, Robine S, Coffey RJ, Reynolds AB (2011) PLoS One 6(5): e19880
    › Primary publication · 21611205 (PubMed) · PMC3096651 (PubMed Central)
  142. Colon-specific delivery of a probiotic-derived soluble protein ameliorates intestinal inflammation in mice through an EGFR-dependent mechanism. Yan F, Cao H, Cover TL, Washington MK, Shi Y, Liu L, Chaturvedi R, Peek RM, Wilson KT, Polk DB (2011) J Clin Invest 121(6): 2242-53
    › Primary publication · 21606592 (PubMed) · PMC3104743 (PubMed Central)
  143. Loss of TFF1 is associated with activation of NF-κB-mediated inflammation and gastric neoplasia in mice and humans. Soutto M, Belkhiri A, Piazuelo MB, Schneider BG, Peng D, Jiang A, Washington MK, Kokoye Y, Crowe SE, Zaika A, Correa P, Peek RM, El-Rifai W (2011) J Clin Invest 121(5): 1753-67
    › Primary publication · 21490402 (PubMed) · PMC3083788 (PubMed Central)
  144. Claudin-2 expression increases tumorigenicity of colon cancer cells: role of epidermal growth factor receptor activation. Dhawan P, Ahmad R, Chaturvedi R, Smith JJ, Midha R, Mittal MK, Krishnan M, Chen X, Eschrich S, Yeatman TJ, Harris RC, Washington MK, Wilson KT, Beauchamp RD, Singh AB (2011) Oncogene 30(29): 3234-47
    › Primary publication · 21383692 (PubMed) · PMC3591522 (PubMed Central)
  145. The concept of hepatic artery-bile duct parallelism in the diagnosis of ductopenia in liver biopsy samples. Moreira RK, Chopp W, Washington MK (2011) Am J Surg Pathol 35(3): 392-403
    › Primary publication · 21317711 (PubMed) · PMC6481167 (PubMed Central)
  146. Epithelial tissues have varying degrees of susceptibility to Kras(G12D)-initiated tumorigenesis in a mouse model. Ray KC, Bell KM, Yan J, Gu G, Chung CH, Washington MK, Means AL (2011) PLoS One 6(2): e16786
    › Primary publication · 21311774 (PubMed) · PMC3032792 (PubMed Central)
  147. STAT6 activation in ulcerative colitis: a new target for prevention of IL-13-induced colon epithelial cell dysfunction. Rosen MJ, Frey MR, Washington MK, Chaturvedi R, Kuhnhein LA, Matta P, Revetta FL, Wilson KT, Polk DB (2011) Inflamm Bowel Dis 17(11): 2224-34
    › Primary publication · 21308881 (PubMed) · PMC3120916 (PubMed Central)
  148. MTGR1 is required for tumorigenesis in the murine AOM/DSS colitis-associated carcinoma model. Barrett CW, Fingleton B, Williams A, Ning W, Fischer MA, Washington MK, Chaturvedi R, Wilson KT, Hiebert SW, Williams CS (2011) Cancer Res 71(4): 1302-12
    › Primary publication · 21303973 (PubMed) · PMC3150168 (PubMed Central)
  149. Combined blockade of Src kinase and epidermal growth factor receptor with gemcitabine overcomes STAT3-mediated resistance of inhibition of pancreatic tumor growth. Nagaraj NS, Washington MK, Merchant NB (2011) Clin Cancer Res 17(3): 483-93
    › Primary publication · 21266529 (PubMed) · PMC3079196 (PubMed Central)
  150. The apolipoprotein E-mimetic peptide COG112 inhibits NF-kappaB signaling, proinflammatory cytokine expression, and disease activity in murine models of colitis. Singh K, Chaturvedi R, Barry DP, Coburn LA, Asim M, Lewis ND, Piazuelo MB, Washington MK, Vitek MP, Wilson KT (2011) J Biol Chem 286(5): 3839-50
    › Primary publication · 21115487 (PubMed) · PMC3030385 (PubMed Central)
  151. Hdac3 is essential for the maintenance of chromatin structure and genome stability. Bhaskara S, Knutson SK, Jiang G, Chandrasekharan MB, Wilson AJ, Zheng S, Yenamandra A, Locke K, Yuan JL, Bonine-Summers AR, Wells CE, Kaiser JF, Washington MK, Zhao Z, Wagner FF, Sun ZW, Xia F, Holson EB, Khabele D, Hiebert SW (2010) Cancer Cell 18(5): 436-47
    › Primary publication · 21075309 (PubMed) · PMC3004468 (PubMed Central)
  152. Distinguishing Ménétrier's disease from its mimics. Rich A, Toro TZ, Tanksley J, Fiske WH, Lind CD, Ayers GD, Piessevaux H, Washington MK, Coffey RJ (2010) Gut 59(12): 1617-24
    › Primary publication · 20926644 (PubMed) · PMC3020399 (PubMed Central)
  153. 7th edition of the AJCC cancer staging manual: stomach. Washington K (2010) Ann Surg Oncol 17(12): 3077-9
    › Primary publication · 20882416 (PubMed)
  154. KSR1 protects from interleukin-10 deficiency-induced colitis in mice by suppressing T-lymphocyte interferon-γ production. Goettel JA, Scott Algood HM, Olivares-Villagómez D, Washington MK, Chaturvedi R, Wilson KT, Van Kaer L, Polk DB (2011) Gastroenterology 140(1): 265-74
    › Primary publication · 20875416 (PubMed) · PMC3008308 (PubMed Central)
  155. Proteomic profiling of mucosal and submucosal colonic tissues yields protein signatures that differentiate the inflammatory colitides. M'Koma AE, Seeley EH, Washington MK, Schwartz DA, Muldoon RL, Herline AJ, Wise PE, Caprioli RM (2011) Inflamm Bowel Dis 17(4): 875-83
    › Primary publication · 20806340 (PubMed) · PMC2997147 (PubMed Central)
  156. Dilated intercellular space in chronic laryngitis and gastro-oesophageal reflux disease: at baseline and post-lansoprazole therapy. Vaezi MF, Slaughter JC, Smith BS, Washington MK, Jerome WG, Garrett CG, Hagaman D, Goutte M (2010) Aliment Pharmacol Ther 32(7): 916-24
    › Primary publication · 20735783 (PubMed)
  157. Targeted inhibition of SRC kinase signaling attenuates pancreatic tumorigenesis. Nagaraj NS, Smith JJ, Revetta F, Washington MK, Merchant NB (2010) Mol Cancer Ther 9(8): 2322-32
    › Primary publication · 20682659 (PubMed) · PMC3449211 (PubMed Central)
  158. Clinical practice patterns and cost-effectiveness of human epidermal growth receptor 2 testing strategies in breast cancer patients. Fitzgibbons P, Washington MK, Murphy D (2010) Cancer 116(16): 3980-1; author reply 3981
    › Primary publication · 20564109 (PubMed)
  159. The deployment of a tissue request tracking system for the CHTN: a case study in managing change in informatics for biobanking operations. Edgerton ME, Grizzle WE, Washington MK (2010) BMC Med Inform Decis Mak : 32
    › Primary publication · 20525187 (PubMed) · PMC2893081 (PubMed Central)
  160. Gastric cancer. Ajani JA, Barthel JS, Bekaii-Saab T, Bentrem DJ, D'Amico TA, Das P, Denlinger C, Fuchs CS, Gerdes H, Hayman JA, Hazard L, Hofstetter WL, Ilson DH, Keswani RN, Kleinberg LR, Korn M, Meredith K, Mulcahy MF, Orringer MB, Osarogiagbon RU, Posey JA, Sasson AR, Scott WJ, Shibata S, Strong VE, Washington MK, Willett C, Wood DE, Wright CD, Yang G, NCCN Gastric Cancer Panel (2010) J Natl Compr Canc Netw 8(4): 378-409
    › Primary publication · 20410333 (PubMed)
  161. Loss of FOXA1/2 is essential for the epithelial-to-mesenchymal transition in pancreatic cancer. Song Y, Washington MK, Crawford HC (2010) Cancer Res 70(5): 2115-25
    › Primary publication · 20160041 (PubMed) · PMC2831111 (PubMed Central)
  162. Protocol for the examination of specimens from patients with gastrointestinal stromal tumor. Rubin BP, Blanke CD, Demetri GD, Dematteo RP, Fletcher CD, Goldblum JR, Lasota J, Lazar A, Maki RG, Miettinen M, Noffsinger A, Washington MK, Krausz T, Cancer Committee, College of American Pathologists (2010) Arch Pathol Lab Med 134(2): 165-70
    › Primary publication · 20121601 (PubMed)
  163. Pathology reporting of neuroendocrine tumors: application of the Delphic consensus process to the development of a minimum pathology data set. Klimstra DS, Modlin IR, Adsay NV, Chetty R, Deshpande V, Gönen M, Jensen RT, Kidd M, Kulke MH, Lloyd RV, Moran C, Moss SF, Oberg K, O'Toole D, Rindi G, Robert ME, Suster S, Tang LH, Tzen CY, Washington MK, Wiedenmann B, Yao J (2010) Am J Surg Pathol 34(3): 300-13
    › Primary publication · 20118772 (PubMed)
  164. Diagnostic utility of IgG and IgM immunohistochemistry in autoimmune liver disease. Moreira RK, Revetta F, Koehler E, Washington MK (2010) World J Gastroenterol 16(4): 453-7
    › Primary publication · 20101770 (PubMed) · PMC2811797 (PubMed Central)
  165. Dietary fat-influenced development of colon neoplasia in Apc Min mice exposed to benzo(a)pyrene. Harris DL, Washington MK, Hood DB, Roberts LJ, Ramesh A (2009) Toxicol Pathol 37(7): 938-46
    › Primary publication · 19841130 (PubMed) · PMC2982189 (PubMed Central)
  166. Assessment of hepatic steatosis by expert pathologists: the end of a gold standard. El-Badry AM, Breitenstein S, Jochum W, Washington K, Paradis V, Rubbia-Brandt L, Puhan MA, Slankamenac K, Graf R, Clavien PA (2009) Ann Surg 250(5): 691-7
    › Primary publication · 19806055 (PubMed)
  167. Aberrant DNA methylation occurs in colon neoplasms arising in the azoxymethane colon cancer model. Borinstein SC, Conerly M, Dzieciatkowski S, Biswas S, Washington MK, Trobridge P, Henikoff S, Grady WM (2010) Mol Carcinog 49(1): 94-103
    › Primary publication · 19777566 (PubMed) · PMC2875385 (PubMed Central)
  168. Long-lived Min mice develop advanced intestinal cancers through a genetically conservative pathway. Halberg RB, Waggoner J, Rasmussen K, White A, Clipson L, Prunuske AJ, Bacher JW, Sullivan R, Washington MK, Pitot HC, Petrini JH, Albertson DG, Dove WF (2009) Cancer Res 69(14): 5768-75
    › Primary publication · 19584276 (PubMed) · PMC2775466 (PubMed Central)
  169. Comparative analysis of PCR-based biomarker assay methods for colorectal polyp detection from fecal DNA. Ausch C, Kim YH, Tsuchiya KD, Dzieciatkowski S, Washington MK, Paraskeva C, Radich J, Grady WM (2009) Clin Chem 55(8): 1559-63
    › Primary publication · 19541867 (PubMed)
  170. Pathology of graft-versus-host disease in the gastrointestinal tract. Washington K, Jagasia M (2009) Hum Pathol 40(7): 909-17
    › Primary publication · 19524102 (PubMed)
  171. A multicenter, double-blinded validation study of methylation biomarkers for progression prediction in Barrett's esophagus. Jin Z, Cheng Y, Gu W, Zheng Y, Sato F, Mori Y, Olaru AV, Paun BC, Yang J, Kan T, Ito T, Hamilton JP, Selaru FM, Agarwal R, David S, Abraham JM, Wolfsen HC, Wallace MB, Shaheen NJ, Washington K, Wang J, Canto MI, Bhattacharyya A, Nelson MA, Wagner PD, Romero Y, Wang KK, Feng Z, Sampliner RE, Meltzer SJ (2009) Cancer Res 69(10): 4112-5
    › Primary publication · 19435894 (PubMed) · PMC2752375 (PubMed Central)
  172. Benign fibroblastic polyps of the colon: a histologic, immunohistochemical, and ultrastructural study. Eslami-Varzaneh F, Washington K, Robert ME, Kashgarian M, Goldblum JR, Jain D (2004) Am J Surg Pathol 28(3): 374-8
    › Primary publication · 15104300 (PubMed)
  173. Analysis of protein expression and gene mutation of c-kit in colorectal neuroendocrine carcinomas. Akintola-Ogunremi O, Pfeifer JD, Tan BR, Yan Y, Zhu X, Hart J, Goldblum JR, Burgart L, Lauwers GY, Montgomery E, Lewin D, Washington K, Bronner M, Xiao SY, Greenson JK, Lamps L, Lazenby A, Wang HL (2003) Am J Surg Pathol 27(12): 1551-8
    › Primary publication · 14657715 (PubMed)
  174. Pathology of mouse models of intestinal cancer: consensus report and recommendations. Boivin GP, Washington K, Yang K, Ward JM, Pretlow TP, Russell R, Besselsen DG, Godfrey VL, Doetschman T, Dove WF, Pitot HC, Halberg RB, Itzkowitz SH, Groden J, Coffey RJ (2003) Gastroenterology 124(3): 762-77
    › Primary publication · 12612914 (PubMed)
  175. Solid-pseudopapillary tumor of the pancreas: challenges presented by an unusual pancreatic neoplasm. Washington K (2002) Ann Surg Oncol 9(1): 3-4
    › Primary publication · 11829428 (PubMed)
  176. Are ulcers a marker for invasive carcinoma in Barrett's esophagus? Data from a diagnostic variability study with clinical follow-up. Montgomery E, Bronner MP, Greenson JK, Haber MM, Hart J, Lamps LW, Lauwers GY, Lazenby AJ, Lewin DN, Robert ME, Washington K, Goldblum JR (2002) Am J Gastroenterol 97(1): 27-31
    › Primary publication · 11808966 (PubMed)
  177. Dysplasia as a predictive marker for invasive carcinoma in Barrett esophagus: a follow-up study based on 138 cases from a diagnostic variability study. Montgomery E, Goldblum JR, Greenson JK, Haber MM, Lamps LW, Lauwers GY, Lazenby AJ, Lewin DN, Robert ME, Washington K, Zahurak ML, Hart J (2001) Hum Pathol 32(4): 379-88
    › Primary publication · 11331954 (PubMed)
  178. Reproducibility of the diagnosis of dysplasia in Barrett esophagus: a reaffirmation. Montgomery E, Bronner MP, Goldblum JR, Greenson JK, Haber MM, Hart J, Lamps LW, Lauwers GY, Lazenby AJ, Lewin DN, Robert ME, Toledano AY, Shyr Y, Washington K (2001) Hum Pathol 32(4): 368-78
    › Primary publication · 11331953 (PubMed)
  179. Targeted disruption of the Kvlqt1 gene causes deafness and gastric hyperplasia in mice. Lee MP, Ravenel JD, Hu RJ, Lustig LR, Tomaselli G, Berger RD, Brandenburg SA, Litzi TJ, Bunton TE, Limb C, Francis H, Gorelikow M, Gu H, Washington K, Argani P, Goldenring JR, Coffey RJ, Feinberg AP (2000) J Clin Invest 106(12): 1447-55
    › Primary publication · 11120752 (PubMed) · PMC387258 (PubMed Central)
  180. Treatment of Ménétrier's disease with a monoclonal antibody against the epidermal growth factor receptor. Burdick JS, Chung E, Tanner G, Sun M, Paciga JE, Cheng JQ, Washington K, Goldenring JR, Coffey RJ (2000) N Engl J Med 343(23): 1697-701
    › Primary publication · 11106719 (PubMed)
  181. Prevalence and prognostic significance of neuroendocrine cells in esophageal adenocarcinoma. Hamilton K, Chiappori A, Olson S, Sawyers J, Johnson D, Washington K (2000) Mod Pathol 13(5): 475-81
    › Primary publication · 10824917 (PubMed)
  182. Concurrent paclitaxel and thoracic irradiation for locally advanced esophageal cancer. Blanke CD, Choy H, Teng M, Beauchamp RD, Leach S, Roberts J, Washington K, Johnson DH (1999) Semin Radiat Oncol 9(2 Suppl 1): 43-52
    › Primary publication · 10210539 (PubMed)
  183. Expression of cell adhesion molecule CD44 in primary tumors of the liver: an immunohistochemical study. Washington K, Telen MJ, Gottfried MR (1997) Liver 17(1): 17-23
    › Primary publication · 9062875 (PubMed)
  184. Endoscopic tattoo agents in the colon. Tissue responses and clinical implications. Lane KL, Vallera R, Washington K, Gottfried MR (1996) Am J Surg Pathol 20(10): 1266-70
    › Primary publication · 8827034 (PubMed)
  185. Gastrointestinal pathology in patients with common variable immunodeficiency and X-linked agammaglobulinemia. Washington K, Stenzel TT, Buckley RH, Gottfried MR (1996) Am J Surg Pathol 20(10): 1240-52
    › Primary publication · 8827031 (PubMed)
  186. Expression of p53 in adenocarcinoma of the gallbladder and bile ducts. Washington K, Gottfried MR (1996) Liver 16(2): 99-104
    › Primary publication · 8740842 (PubMed)
  187. Pathology of the pancreas in bone marrow transplant patients. Washington K, Peters W, Gottfried MR (1993) Hum Pathol 24(2): 152-9
    › Primary publication · 8432511 (PubMed)
  188. Pathology of the liver in severe combined immunodeficiency and DiGeorge syndrome. Washington K, Gossage DL, Gottfried MR (1993) Pediatr Pathol 13(4): 485-504
    › Primary publication · 8372033 (PubMed)
  189. Inflammatory cloacogenic polyp in a child: part of the spectrum of solitary rectal ulcer syndrome. Washington K, Rourk MH, McDonagh D, Oldham KT (1993) Pediatr Pathol 13(4): 409-14
    › Primary publication · 8372025 (PubMed)
  190. Nodular regenerative hyperplasia in partial hepatectomy specimens. Washington K, Lane KL, Meyers WC (1993) Am J Surg Pathol 17(11): 1151-8
    › Primary publication · 8214260 (PubMed)
  191. Pathology of the pancreas in severe combined immunodeficiency and DiGeorge syndrome: acute graft-versus-host disease and unusual viral infections. Washington K, Gossage DL, Gottfried MR (1994) Hum Pathol 25(9): 908-14
    › Primary publication · 8088766 (PubMed)
  192. Tissue culture of epithelium derived from Barrett's oesophagus. Washington K, Gottfried MR, Telen MJ (1994) Gut 35(7): 879-83
    › Primary publication · 8063213 (PubMed) · PMC1374832 (PubMed Central)
  193. Hepatic adenoma: MR characteristics and correlation with pathologic findings. Paulson EK, McClellan JS, Washington K, Spritzer CE, Meyers WC, Baker ME (1994) AJR Am J Roentgenol 163(1): 113-6
    › Primary publication · 8010195 (PubMed)
  194. CT of the liver in patients with metastatic breast carcinoma treated by chemotherapy: findings simulating cirrhosis. Young ST, Paulson EK, Washington K, Gulliver DJ, Vredenburgh JJ, Baker ME (1994) AJR Am J Roentgenol 163(6): 1385-8
    › Primary publication · 7992734 (PubMed)
  195. Tetracycline-induced bile duct paucity and prolonged cholestasis. Hunt CM, Washington K (1994) Gastroenterology 107(6): 1844-7
    › Primary publication · 7958700 (PubMed)
  196. Anaplastic renal cell carcinoma following neuroblastoma. Krigman HR, Bentley RC, Strickland DK, Miller CR, Dehner LP, Washington K (1995) Med Pediatr Oncol 25(1): 52-9
    › Primary publication · 7753003 (PubMed)
  197. Secondary tumors of the gastrointestinal tract: surgical pathologic findings and comparison with autopsy survey. Washington K, McDonagh D (1995) Mod Pathol 8(4): 427-33
    › Primary publication · 7567944 (PubMed)
  198. Expression of the cell adhesion molecule CD44 in gastric adenocarcinomas. Washington K, Gottfried MR, Telen MJ (1994) Hum Pathol 25(10): 1043-9
    › Primary publication · 7523275 (PubMed)
  199. Dye binding probes of lipid-binding structures. An investigation of 2-p-toluidinylnaphthylene-6-sulfonate binding to human and bovine prothrombin and fragment 1 in the presence and absence of calcium and magnesium ions. Sarasua MM, Washington K, Gabriel DA, Bourne C, Kabis CW, Hiskey RG, Koehler KA (1983) Biochim Biophys Acta 742(1): 257-64
    › Primary publication · 6687436 (PubMed)
  200. Utilization of heavy-atom effect quenching of pyrene fluorescence to determine the intramembrane distribution of halothane. Washington K, Sarasua MM, Koehler LS, Koehler KA, Schultz JA, Pedersen LG, Hiskey RG (1984) Photochem Photobiol 40(6): 693-701
    › Primary publication · 6549213 (PubMed)
  201. Helicobacter pylori-like microorganisms and chronic active gastritis in ferrets. Gottfried MR, Washington K, Harrell LJ (1990) Am J Gastroenterol 85(7): 813-8
    › Primary publication · 2371981 (PubMed)
  202. Gastrointestinal cryptococcosis. Washington K, Gottfried MR, Wilson ML (1991) Mod Pathol 4(6): 707-11
    › Primary publication · 1788263 (PubMed)